Profound Medical Corp.

TSX:PRN.TO

Medical - Devices

Healthcare
$9.83 +1.18%

+$0.11 today

Market cap
$360.04M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $5.23High $12.40

Volume 0.00M

Average 0.01M

PRN.TO Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Profound Medical Corp.TSX: PRN.TO

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 8.4% from a year ago

Cash & equivalents stood at $50.33M at the end of Q1 FY2026, up 8.4% from a year earlier and down 15.6% from the prior quarter. Over 3 fiscal years it compounded at +8.6% a year.

Context

  • Cash & equivalents amounted to 68.5% of total assets at the end of Q1 FY2026, down 7.8 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +8.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$50.33M-15.6% QoQ
Last fiscal yearDec 2025
$59.61M+8.6% YoY
Year agoMar 2025
$46.43M+8.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.4%——
1 year+8.6%——
3-year CAGR+8.6%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
59.61M USD
Year-over-year change
+8.6%
4-year CAGR
-2.9%

Cash & Equivalents vs competitors

How PRN.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +8.4% is the 5th highest of 6, against a peer median of +37.2%.
  • Cash & equivalents amounts to 68.5% of total assets for PRN.TO, versus a peer median of 15.3%.
PRN.TO Competitors
Cash & Equivalents for PRN.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DR.TOMedical Facilities CorporationMar 2026$86.36M USD+31.4%+7.5%31.1%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$58.54M USD+113.2%+48.1%40.2%
PRN.TOProfound Medical Corp.Mar 2026$50.33M USD+8.4%+8.6%68.5%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$42.91M CAD+150.8%+30.5%15.3%
CRRX.TOCareRx CorporationMar 2026CA$15.32M CAD+37.2%-20.2%6.2%
HLS.TOHLS Therapeutics Inc.Mar 2026$12.33M USD-30.4%-17.3%9.4%
Peer median (excluding PRN.TO) —+37.2%+7.5%15.3%

Competitors are the stored peer set for PRN.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents67.15M46.52M26.21M54.91M59.61M
Short-term Investments00000
Net Receivables1.4M5.89M7.29M7.05M5.24M
Inventory7.35M8.01M6.99M5.8M8.22M
Other Current Assets0511.6K002.19M
Total Current Assets76.48M62.59M41.9M69.07M75.95M
Property, Plant & Equipment (Net)1.9M1.72M1.53M821.01K880.39K
Goodwill2.69M0000
Intangible Assets1.44M680K490K261K137.75K
Long-term Investments4.58M000299.45K
Tax Assets(4.58M)0087K63.35M
Other Non-current Assets3.62M0003
Total Non-current Assets9.65M2.4M2.02M1.17M64.67M
Total Assets86.78M64.42M43.91M70.23M140.62M
Account Payables3.18M2.03M865K1.32M1.56M
Short-term Debt247.65K527.74K2.1M1.74M212.61K
Tax Payables0298K000
Deferred Revenue477K471K721K419K444.19K
Other Current Liabilities352614.09K1.42M1.03M1.31M
Total Current Liabilities4.16M4.19M6.37M6.57M6.06M
Long-term Debt06.71M5M2.92M4.49M
Deferred Tax Liabilities0059K063.28M
Deferred Revenue (Non-current)875K764K728K49K387.29K
Other Non-current Liabilities867.72K770.92K74K71K78.86K
Total Non-current Liabilities1.99M8.31M6.37M3.25M68.24M
Total Liabilities6.16M12.42M12.73M9.81M74.3M
Common Stock217.75M207.69M217.39M281.55M323.25M
Retained Earnings(159.36M)(191.08M)(217.93M)(245.17M)(287.22M)
Accumulated OCI4.71M16.99M12.03M2.74M5.02M
Other Stockholders Equity00000
Minority Interest00000
Total Equity80.62M52M31.18M60.42M66.31M
Total Debt1.38M8.3M7.87M5.12M4.7M
Net Debt(65.78M)(38.29M)(18.35M)(49.79M)(54.91M)

Profound Medical Corp.

TSX:PRN.TO

Intrinsic Alpha fair value

Locked

Current Price

$9.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.